Send us Feedback

Repligen (RGEN)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

RGEN » Topics » DOCUMENTS INCORPORATED BY REFERENCE

This excerpt taken from the RGEN 10-K filed Jun 11, 2009.

DOCUMENTS INCORPORATED BY REFERENCE

FACE="Times New Roman" SIZE="2">Portions of the Company’s definitive Proxy Statement in connection with the 2009 annual meeting of Stockholders are incorporated by reference into Part III of this Form 10-K.

STYLE="font-size:4px;margin-top:0px;margin-bottom:0px"> 

 

STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000"> 





Table of Contents


This excerpt taken from the RGEN 10-K filed Jun 13, 2008.

DOCUMENTS INCORPORATED BY REFERENCE

FACE="Times New Roman" SIZE="2">Portions of the Company’s definitive Proxy Statement in connection with the 2008 annual meeting of Stockholders are incorporated by reference into Part III of this Form 10-K.

STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"> 

 

STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000"> 





Table of Contents


This excerpt taken from the RGEN 10-K filed Jun 14, 2005.

DOCUMENTS INCORPORATED BY REFERENCE

 

The Company intends to file a definitive proxy statement pursuant to Regulation 14A within 120 days of the end of the fiscal year ended March 31, 2005. Portions of such proxy statement are incorporated by reference in Part III of this Form 10-K.

EXCERPTS ON THIS PAGE:

10-K
Jun 11, 2009
10-K
Jun 13, 2008
10-K
Jun 14, 2005

RELATED TOPICS for RGEN:

"DOCUMENTS INCORPORATED BY REFERENCE" elsewhere:

AEterna Zentaris (AEZS)
Affymax (AFFY)
Alnylam Pharmaceuticals (ALNY)
Anika Therapeutics (ANIK)
BioCryst Pharmaceuticals (BCRX)
Cadence Pharmaceuticals (CADX)
Cerus (CERS)
Dyax (DYAX)
Enzon Pharmaceuticals (ENZN)
EPIX Pharmaceuticals (EPIX)
Exelixis (EXEL)
Halozyme Therapeutics (HALO)
Heska (HSKA)
Endo Pharmaceuticals Solutions Inc. (IDEV)
Idenix Pharmaceuticals (IDIX)
ImmunoGen (IMGN)
InterMune (ITMN)
Metabasis Therapeutics (MBRX)
Medivation (MDVN)
Medarex (MEDX)
Micromet (MITI)
Biota Pharmaceuticals, Inc. (NABI)
Neurocrine Biosciences (NBIX)
NGEN, INC. (NGEN)
Neurobiological Technologies (NTII)
ARCA biopharma, Inc. (NUVO)
Optimer Pharmaceuticals (OPTR)
Pharmacopeia Drug Discovery (PCOP)
Peregrine Pharmaceuticals (PPHM)
Questcor Pharmaceuticals (QSC)
Seattle Genetics (SGEN)
Sangamo BioSciences (SGMO)
Sequenom (SQNM)
Savient Pharmaceuticals (SVNT)
Trubion Pharmaceuticals (TRBN)
Tercica (TRCA)
Targacept (TRGT)
SYNAGEVA BIOPHARMA CORP (TRMS)
Vanda Pharmaceuticals (VNDA)
XOMA (XOMA)
ZymoGenetics (ZGEN)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki